-
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS
de Jonge, A. V., Duetz, C., Bruins, W. S. C., Korst, C. L. B. M., Rentenaar, R., Cosovic, M., Eken, M., Twickler, I., Nijland, M., van der Poel, M. W. M., de Heer, K., Klerk, C. P. W., Strobbe, L., Oosterveld, M., Boersma, R., Koene, H. R., Roemer, M. G. M., van Werkhoven, E., Chamuleau, M. E. D. & Mutis, T., 12 Mar 2024, In: Blood. 8, 5, p. 1094-1104 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients
de Jonge, A. V., van Werkhoven, E., Dinmohamed, A. G., Nijland, M., Zwinderman, A. H., Bossuyt, P. M., Veldhuis, M. S., Rutten, E. G. G. M., Mous, R., Vermaat, J. S. P., Sandberg, Y., de Jongh, E., Bilgin, Y. M., Boersma, R., Koene, H., Kersten, M. J., de Jong, D. & Chamuleau, M. E. D., 1 Dec 2023, In: Blood Cancer Journal. 13, 1, 85.Research output: Contribution to journal › Article › Academic › peer-review
-
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial
Vliek, S., Hilbers, F. S., van Werkhoven, E., Mandjes, I., Kessels, R., Kleiterp, S., Lips, E. H., Mulder, L., Kayembe, M. T., Loo, C. E., Russell, N. S., Vrancken Peeters, M-J. T. F. D., Holtkamp, M. J., Schot, M., Baars, J. W., Honkoop, A. H., Vulink, A. J. E., Imholz, A. L. T., Vrijaldenhoven, S., van den Berkmortel, F. W. P. J., & 11 others, 1 Dec 2023, In: NPJ Breast Cancer. 9, 1, 75.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
